Cardiovascular Diseases

Plasma Ceramides – A Novel Biomarker of Unstable Atherosclerotic Cardiovascular Disease

Jeffrey (Jeff) W. Meeusen, Ph.D., discusses studies of plasma ceramides in three different patient populations.

Publish Date: 10/31/2016

Genetic Risk Information for Coronary Heart Disease Leads to Lower Bad Cholesterol

A group of researchers led by Mayo Clinic has discovered that disclosing genetic risk for coronary heart disease results in lower low-density lipoprotein cholesterol (LDL), also known as bad cholesterol.

Publish Date: 6/15/2016

Severe Calcific Mitral Valve Stenosis

Sameh M. Said, M.D., a cardiovascular surgeon at Mayo Clinic's campus in Rochester, Minnesota, discusses surgical treatment options for severe calcific mitral valve stenosis. Mitral valve surgery in the presence of severe annular calcification is associated with degenerative valvular disease. About 2.8 percent of patients have severe annular calcifications.

Although mitral valve replacement with annular debridement is the gold standard for treatment, says Dr. Said, mitral valve bypass is a safe and more-practical option in patients at high risk.

Publish Date: 4/22/2016

Re-operative Cardiac Surgery: When 1 Operation is Just Not Enough

Joseph A. Dearani, M.D., and Sameh M. Said, M.D., cardiovascular surgeons at Mayo Clinic's campus in Rochester, Minnesota, discuss considerations surrounding cardiac re-operation surgery with cardiologists Naser M. Ammash, M.D., and Rajiv Gulati, M.D., Ph.D.

Publish Date: 2/3/2016

play 1 2 3 4

Cardiovascular Diseases

Ebstein’s Anomaly

Mayo Clinic chair of Cardiovascular Diseases, Charanjit Rihal, M.D., and Joseph Dearani, M.D., chair of Cardiovascular Surgery discuss about Ebstein’s Anomaly and surgical treatment options.

View Video

Atenolol vs. Losartan in Patients With Marfan Syndrome

Robert J. Widmer, M.D., Ph.D., and Juan M. Bowen, M.D., compare losartan versus atenolol for reducing the aortic dilatation rate and discuss the results of the Atenolol versus Losartan in children and young adults with Marfan's syndrome study.

View Video

Brugada Syndrome vs Pattern: What You Should Know

Mayo Clinic associate professor of Medicine, Rajiv Gulati, M.D., Ph.D., and Suraj Kapa, M.D., assistant professor of medicine discuss Brugada Syndrome versus Brugada Pattern.

View Video

Any Hope For Renal Denervation After SYMPLICITY HTN-3?

Peter A. Brady, M.B., Ch.B., M.D., and Rajiv Gulati, M.D., Ph.D, discuss renal denervation following the SYMPLICITY HTN-3 trial.

View Video

Making Decisions With, Not for, Patients

Mayo Clinic advanced cardiology fellow, Selma Mohammed, MBBS, and Victor Montori, M.D., Director, Knowledge and Evaluation Research Unit, discuss to the importance of letting the patients make decisions about their healthcare through the use of decision aids

View Video

Grand Rounds: A Fantastic Voyage: Recombinant Drug Design to Breakthroughs in Electronics to Novel Treatments for Stroke

Thomas Brott, M.D., presents A FantasticVoyage:Recombinant Drug Design to Breakthroughs in Electronics to Novel Treatments for Stroke.

View Video

Grand Rounds: Diastolic Exercise Echo: A Diagnostic Tool for HFpEF

In this Cardiovascular Grand Rounds Jae K. Oh, M.D., discusses exercise echocardiography as a diagnostic test for heart failure with preserved ejection fraction.

View Video

Grand Rounds: Aortic Stenosis and Calcification

In this Cardiovascular Grand Rounds, Maurice E. Sarano, M.D., and Jordan D. Miller, Ph.D., discuss aortic valve stenosis and calcification.

View Video

Refer a patient

  1. Arizona
  2. Florida
  3. Minnesota

Online referrals

Referring your patient

Download a referral form